Fairmount Funds Management LLC, Ten Percent Owner Other at Cogent Biosciences, Inc. (COGT), bought 1,200,000 shares at $8.25 ($9.9M) on 2022-06-16, disclosed to the SEC on 2022-06-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| SYRE | SELL | 2026-06-23 | $399.7M | — | Filing → |
| VRDN | BUY | 2026-05-13 | $20.0M | — | Filing → |
| ZBIO | BUY | 2026-04-01 | $3.0M | — | Filing → |